Inactive Instrument

Company Guided Therapeutics Inc OTC Bulletin Board

Equities

US40171F1057

Advanced Medical Equipment & Technology

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Guided Therapeutics Inc

Business Summary

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.

Sales per Business

USD in Million2022Weight2023Weight Delta
Non-invasive Cervical Cancer Detection Device
100.0 %
0 100.0 % 0 100.0 % +653.85%

Sales per region

USD in Million2022Weight2023Weight Delta
China, Southeast Asia (including Indonesia), Central & Eastern Europe and Saudi Arabia
100.0 %
0 100.0 % 0 100.0 % +653.85%

Managers

Managers TitleAgeSince
Chief Executive Officer 68 92-10-26
Founder 68 92-10-26

Members of the board

Members of the board TitleAgeSince
Director/Board Member 74 06-04-09
Director/Board Member 67 16-11-09
Chief Executive Officer 68 92-10-26
Chairman 65 07-02-28
Director/Board Member 56 23-03-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 900 0 0 56.20 %
Stock B 0 400 0 0
Stock C 0 2,700 0 0
Stock D 0 1,000 0 0
Stock E 0 300 0 0
Stock F 1 55,613,449 31,255,568 ( 56.20 %) 0
Stock G 0 500 0 0

Shareholders

NameEquities%Valuation
GPB Capital Holdings LLC
17.54 %
9,135,152 17.54 % 1 M $
6,119,162 11.75 % 709 823 $
5,177,896 9.939 % 600 636 $
Auctus Fund Management LLC
7.838 %
4,083,217 7.838 % 473 653 $
1,498,320 2.876 % 173 805 $
DRG Services LLC
1.920 %
1,000,000 1.920 % 116 000 $
614,370 1.179 % 71 267 $
538,551 1.034 % 62 472 $
Mark Faupel
0.3103 %
161,655 0.3103 % 18 752 $
112,773 0.2165 % 13 082 $
NameEquities%Valuation
2,401 88.93 % 279 $
299 11.07 % 35 $
NameEquities%Valuation
440 42.88 % 51 $
260 25.34 % 30 $
Auctus Fund Management LLC
19.49 %
200 19.49 % 23 $
John Imhoff
0.9747 %
10 0.9747 % 1 $
NameEquities%Valuation
300 68.49 % 35 $
38 8.676 % 4 $
NameEquities%Valuation
250 28.31 % 29 $
233 26.39 % 27 $
Auctus Fund Management LLC
11.89 %
105 11.89 % 12 $
50 5.663 % 6 $
NameEquities%Valuation
97 18.65 % 11 $
88 16.92 % 10 $

Company contact information

Guided Therapeutics, Inc.

5835 Peachtree Corners East Suite B

30092, Norcross

+678 329 7933

http://www.guidedinc.com
address Guided Therapeutics Inc
  1. Stock Market
  2. Equities
  3. GTHP Stock
  4. Stock
  5. Company Guided Therapeutics Inc